ACLARIS THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.165 USD | -0.43% |
|
-11.07% | +10.95% |
| May. 07 | Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
| May. 07 | Earnings Flash (ACRS) ACLARIS THERAPEUTICS Reports Q1 Revenue $2.4M, vs. Street Est of $2M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -0.43% | -11.07% | +10.95% | -86.00% | -79.56% | 83.38M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- ACRS Stock
- Charts Aclaris Therapeutics, Inc.
- Comparison Chart
